Skip to main content

Enlivex Ltd.

corporate_fare Company Profile

Enlivex Ltd.

ENLV·NASDAQ·Crypto Assets·CIK 0001596812

Enlivex Ltd. is a company incorporated under the laws of the State of Israel. The company was originally incorporated as Bioblast Pharma Ltd. on January 22, 2012. On March 26, 2019, Bioblast Pharma Ltd. merged with Enlivex R&D (formerly Enlivex Therapeutics Ltd.), with Enlivex R&D becoming a wholly owned subsidiary of Bioblast. Following the merger, Bioblast Pharma Ltd. changed its name to Enlivex Therapeutics Ltd. In February 2026, the company changed its name to Enlivex Ltd. Its primary operating subsidiary, Enlivex R&D, was initially incorporated as Tolarex Ltd. in September 2005 in Israel. In February 2010, Tolarex Ltd. changed its name to Enlivex Therapeutics Ltd., and after the merger, to Enlivex Therapeutics R&D Ltd. In June 2021, Enlivex Therapeutics RDO Ltd. was established in Israel as a wholly owned subsidiary. The company also has a wholly owned U.S. subsidiary, Enlivex Therapeutics Inc., incorporated in Delaware. Enlivex Ltd.'s principal executive offices are located at 14 Einstein Street, Ness Ziona, Israel 7403618. The company's capital expenditures for the three years ended December 31, 2025, 2024, and 2023 were insignificant.

Enlivex Ltd. (NASDAQ:ENLV) is a publicly traded company in the Crypto Assets sector. Wiseek has independently scored 44 items for ENLV at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Enlivex Reports $1.1B RAIN Token Treasury, NAV Per Share at $66.16
  • Enlivex's Allocetra™ Lands FDA RMAT Designation for Knee Osteoarthritis, Paving the Way for Expedited Review
  • Enlivex Announces 1-for-15 Reverse Split to Avoid Nasdaq Delisting
  • Enlivex Finalizes 1-for-15 Reverse Stock Split, Effective July 9th, to Address Nasdaq Compliance
  • Enlivex's RAIN Token to List on Gate Exchange, Boosting Liquidity for $1.14B Treasury

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
$1.24B
Diluted EPS
$25.48
Op. Cash Flow
-$10.42M
Free Cash Flow
-$10.48M
Operating Income
-$15.03M
Cash & Equivalents
$1.89M
Debt / Equity
0.00×
Shares Outstanding
237.38M sh
Source: 20-F · filed 2026-03-25 · accession 0001213900-26-033857

Insider Transactions

ENLV files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$1.07 +1.90% today
52-week range · as of 2026-11-18 $1 – $434.4
Market cap
$1.61M
Volume
41K (0.9× avg)
3-mo avg 45.7K
Live data · 2026-11-22 12:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ENLV - Filings & News (Page 2)

ENLV
Jul 20, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.01
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Jul 13, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $7.68
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Jul 07, 2026, 8:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.4698
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Jul 07, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.456
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Jun 24, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.5833
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Jun 22, 2026, 8:50 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.5999
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
May 28, 2026, 8:05 AM EDT
Filing Type: 6-K
Importance Score:
10
Price at Filing: $0.8168
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
May 27, 2026, 8:05 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.6577
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
May 18, 2026, 8:02 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7014
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
May 15, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7206
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
May 01, 2026, 4:16 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.814
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Apr 21, 2026, 4:15 PM EDT
Filing Type: F-3
Importance Score:
8
Price at Filing: $0.900
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Apr 21, 2026, 8:32 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.8928
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Apr 08, 2026, 8:33 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.8899
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Mar 26, 2026, 8:32 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Mar 25, 2026, 8:40 AM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $1.27
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Mar 24, 2026, 8:34 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.06
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Mar 23, 2026, 8:02 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Mar 20, 2026, 4:05 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $1.02
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
ENLV
Feb 10, 2026, 8:02 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $1.07 info
Change: Reverse Stock Split info
Market Cap: $1.609M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets